Motus GI Receives FDA Clearance to Market Pure-Vu® GEN2

52

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the second-generation Pure-Vu® System (“Pure-Vu® GEN2”) to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. “Inadequate …

 

http://www.businesswire.com/news/home/20190611005305/en/Motus-GI-Receives-FDA-Clearance-Market-Pure-Vu%C2%AE/